# A Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes Mellitus

> **NCT02749435** · — · TERMINATED · sponsor: **AstraZeneca** · enrollment: 57 (actual)

## Conditions studied

- Type II Diabetes Mellitus

## Interventions

- **OTHER:** Use of digital disease management tool in participants with T2DM

## Key facts

- **NCT ID:** NCT02749435
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05-03
- **Primary completion:** 2016-10-13
- **Final completion:** 2016-10-13
- **Target enrollment:** 57 (ACTUAL)
- **Why stopped:** The study was stopped due to lack of recruitment.
- **Last updated:** 2017-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02749435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02749435, "A Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02749435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*